The Brigham and Women's Hospital v. Teva Pharmaceuticals
The Brigham and Women's Hospital v. Teva Pharmaceuticals
Opinion
NOTE: This order is nonprecedential.
<Muiteb $>tate~ QCourt of §ppeaI~ for tbe jfeberaI QCircuit
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. AND AMGEN, INC., Plaintiffs·Appellees, Al'lD
NPS PHARMACEUTICALS, INC., Plaintiff-Appellee, v. TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD., AND BARR LABORATORIES, Defendants·Appellants.
2011·1217
Appeal from the United States District Court for the District of Delaware in case no. 08·CV·0464, Judge Har· vey Bartle, III.
ON MOTION
Before BRYSON, Circuit Judge. ORDER BRIGHAM AND WOMENS v. TEVA PHARMA 2
Teva Pharmaceuticals USA, Inc., Teva Pharmaceuti· cal Industries Ltd., and Barr Laboratories, Inc. (collec· tively Teva) move to stay proceedings in this case pending the court's disposition in Therasense, Inc. v. Becton, Dickinson & Co., 2008·1511 et al. The appellees oppose. Upon consideration thereof, IT Is ORDERED THAT: (1) The motion to stay proceedings is denied. (2) Teva's initial brief is due within 60 days from the date of filing of this order.
FOR THE COURT
MAR 21 2011 /s/ Jan Horbaly Date Jan Horbaly Clerk cc: John D. Murnane, Esq. John L. North, Esq. FlUB II.S. COURT 01'Ai'PEALS FOIR Mary W. Bourke, Esq. THE FEDEfl/',I. r.lRCUIT s23 MAR 21 2011
Reference
- Status
- Unpublished